Lithium tris[μ3-[3-(hydroxy-κO)-4-[(4-methyl-1-piperazinyl)methyl]-2(1H)-pyridinonato(2-)-κN1:κO2:κO2]]tris[[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]ruthenium] CAS 835614-74-9
Purity 97%+In StockPharmaceutical Standards
CAS No.
835614-74-9
Molecular Formula
-
Molecular Weight
N/A
Category
Pharmaceutical Standards / API Standards
Availability
In Stock
Chemical Structure
Description
CATO supplies Lithium tris[μ3-[3-(hydroxy-κO)-4-[(4-methyl-1-piperazinyl)methyl]-2(1H)-pyridinonato(2-)-κN1:κO2:κO2]]tris[[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]ruthenium] (CAS 835614-74-9), a pharmaceutical standards reference standard manufactured under ISO 17034 accreditation. Batch-specific COA and technical support are available on request.